Pular para o conteúdo principal
Ranking Invest

SCPH - scPharmaceuticals Inc.

Segmento: HealthcarescPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Análise Ranking Invest

Valuation estimado
-$ 210.40 Mi
Último Balanço Atualizado: 1T2025

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

-$ 5.13 Mi

Dívida Líquida

-$ 5.19 Mi

L4T

-$ 90.78 Mi

MM4T

-221.36%

Indicadores Básicos

ROE

1770.67%

Índices de Previsibilidade

Faturamento

F0.56

Lucro

A0.07

Margem

D0.92

Índices de Tendência

Faturamento

A11.02

Lucro

G-12.24

Margem

F-4.80

Índices de Endividamento

DIV/PAT

1.01

DIV/L4T

0.06

Dívidas
Cotação
Gráfico Lucro/Faturamento X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.